AXGN Q1 2019 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q1 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$23M+34.9% YoY

Gross Profit

$20M84.0% margin

Operating Income

-$10M-43.8% margin

Net Income

-$10M-40.8% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

-0.6%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$160M

Total Liabilities

$20M

Stockholders' Equity

$141M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$17M	+34.9%
Gross Profit	$20M	$15M	+34.5%
Operating Income	-$10M	-$5M	-104.4%
Net Income	-$10M	-$6M	-68.5%